O27: Interaction of Cancer Stem Cells and Microglia in Glioblastoma Multiforme

Authors

  • Ali Gorji a. Shefa Neuroscience Research Center, Khatam-Alanbia Hospital, Tehran, Iran b. Department of Neurosurgery, Westfälische Wilhelms-Universität Münster, Münster, Germany c. Department of Neuroscience, Mashhad University of Medical Sciences, Mashhad, Iran
  • Amir Azarhomayoun Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Sara Abdolahi Shefa Neuroscience Research Center, Khatam-Alanbia Hospital, Tehran, Iran
  • Sepideh Ghasemi Shefa Neuroscience Research Center, Khatam-Alanbia Hospital, Tehran, Iran
Abstract:

Malignant gliomas are highly invasive brain tumors with the occurrence of multiple microglia/macrophages in the tumor microenvironment. Macrophages/microglia that found in glioma microenvironment, as tumor-infiltrating immune cells, can play a harmful role in tumor progression. In addition, glioblastoma multiforme (GBM) contains multiple aberrant differentiation and tumorigenic cancer stem cells (CSCs) that contribute to tumor heterogeneity and resistance to anti-cancer therapies. The present study was aimed to understand the interaction between microglial cells and CSCs in a co-culture system. Specific markers used for the characterization of CSCs and microglia in GBM tissues obtained from patients. Then, we applied a co-culture system consisting of permeable membrane allowing secreted soluble factors to diffuse. Measuring the effects of cytokines secreted by activated and non-activated microglia on CSCs, MTS cell proliferation assay were performed. Cell viability in CSCs treated with non-activated microglia was significantly reduced compared to the group that treated with activated microglia. The activated microglia/macrophages may interfere in the process of tumor angiogenesis, metastasis niches, recurrence and support tumour invasiveness.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Cancer Stem Cells in Glioblastoma Multiforme

AIM To identify and characterize cancer stem cells (CSC) in glioblastoma multiforme (GBM). METHODS Four-micrometer thick formalin-fixed paraffin-embedded GBM samples from six patients underwent 3,3-diaminobenzidine (DAB) and immunofluorescent (IF) immunohistochemical (IHC) staining for the embryonic stem cell (ESC) markers NANOG, OCT4, SALL4, SOX2, and pSTAT3. IF IHC staining was performed to...

full text

Cancer stem cells and microglia in the processes of glioblastoma multiforme invasive growth

The development of antitumor medication based on autologous stem cells is one of the most advanced methods in glioblastoma multiforme (GBM) treatment. However, there are no objective criteria for evaluating the effectiveness of this medication on cancer stem cells (CSCs). One possible criterion could be a change in the number of microglial cells and their specific location in the tumor. The pre...

full text

Glioblastoma Multiforme Stem Cells

Glioblastoma multiforme (GBM) is an aggressive, malignant, and lethal brain tumor, resistant to all current forms of treatment. The rapidly emerging focus on cancer stem cells embodies a paradigm shift in our understanding of tumor pathogenesis, while the development of powerful genome-wide screening techniques has provided cause for optimism related to the development of more reliable therapie...

full text

Cancer Stem Cell Hierarchy in Glioblastoma Multiforme

Glioblastoma multiforme (GBM), an aggressive tumor that typically exhibits treatment failure with high mortality rates, is associated with the presence of cancer stem cells (CSCs) within the tumor. CSCs possess the ability for perpetual self-renewal and proliferation, producing downstream progenitor cells that drive tumor growth. Studies of many cancer types have identified CSCs using specific ...

full text

Brain Cancer Stem Cells: Current Status on Glioblastoma Multiforme

Glioblastoma multiforme (GBM), an aggressive brain tumor of astrocytic/neural stem cell origin, represents one of the most incurable cancers. GBM tumors are highly heterogeneous. However, most tumors contain a subpopulation of cells that display neural stem cell characteristics in vitro and that can generate a new brain tumor upon transplantation in mice. Hence, previously identified molecular ...

full text

Association of Glioblastoma Multiforme Stem Cell Characteristics, Differentiation, and Microglia Marker Genes with Patient Survival

Patients with glioblastoma multiforme (GBM) are at high risk to develop a relapse despite multimodal therapy. Assumedly, glioma stem cells (GSCs) are responsible for treatment resistance of GBM. Identification of specific GSC markers may help to develop targeted therapies. Here, we performed expression analyses of stem cell (ABCG2, CD44, CD95, CD133, ELF4, Nanog, and Nestin) as well as differen...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 6  issue 2

pages  27- 27

publication date 2018-04

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023